{"transactions":[{"id":2578310,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":135230,"kind":"person","name":"Falconer Ester","position":1,"cik":"0001844479","reported_name":"Falconer Ester","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Share option (right to buy)","published_at":"2021-09-03T20:18:57.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":875000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on January 1, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":875000,"derivative":{"exercise_price":0.31,"expiration_date":"2029-01-01","underlying":"Common Shares","underlying_shares":875000},"source":{"system":"sec-edgar","filing":"0001209191-21-054749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121054749/doc4.xml","form_type":"4"}},{"id":2578309,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":135230,"kind":"person","name":"Falconer Ester","position":1,"cik":"0001844479","reported_name":"Falconer Ester","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Shares","published_at":"2021-09-03T20:18:57.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":875000,"price":16.89,"value":14778750.0,"ownership":{"direct":true},"balance_after":875000,"source":{"system":"sec-edgar","filing":"0001209191-21-054749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121054749/doc4.xml","form_type":"4"}},{"id":2673264,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":135230,"kind":"person","name":"Falconer Ester","position":1,"cik":"0001844479","reported_name":"Falconer Ester","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Shares","published_at":"2021-06-10T21:00:54.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":1000000,"price":25.5,"value":25500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-022987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022987/doc4.xml","form_type":"4"}},{"id":2740483,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":135230,"kind":"person","name":"Falconer Ester","position":1,"cik":"0001844479","reported_name":"Falconer Ester","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-04-24T00:00:13.000Z","date":"2021-03-19","kind":"exercise","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price reported above was converted from the Canadian exercise price of CAD $0.0450 using an exchange rate on August 4, 2015 of CAD $1.313 = US $1.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of the date of the transaction, the option was fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.0343,"expiration_date":"2025-08-04","underlying":"Common Shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000899243-21-016935","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321016935/doc4.xml","form_type":"4"}},{"id":2740482,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":135230,"kind":"person","name":"Falconer Ester","position":1,"cik":"0001844479","reported_name":"Falconer Ester","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Shares","published_at":"2021-04-24T00:00:13.000Z","date":"2021-03-19","kind":"exercise","acquired":true,"shares":1000000,"price":0.0343,"value":34300.0,"ownership":{"direct":true},"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0000899243-21-016935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321016935/doc4.xml","form_type":"4"}}]}